TY - JOUR
T1 - Synthetic biology confronts publics and policy makers
T2 - Challenges for communication, regulation and commercialization
AU - Bubela, Tania
AU - Hagen, Gregory
AU - Einsiedel, Edna
PY - 2012/3
Y1 - 2012/3
N2 - The novelty of synthetic biology lies in the use of synthesized parts that can be arranged to make useful products. Such advanced, high-throughput genetic engineering projects redesign and fabricate existing biological systems as well as new biological parts, devices and systems that do not occur in nature. This Opinion discusses challenges raised by synthetic biology for public acceptance, regulation, commercialization and the emerging global issue of access to genetic resources and information. As with all new fields of research, maintaining the trust of the public and policy regulators is paramount. Hype and exaggerated claims are counterproductive to developing adaptive and ethically sound regulatory models responsive to stakeholder concerns.
AB - The novelty of synthetic biology lies in the use of synthesized parts that can be arranged to make useful products. Such advanced, high-throughput genetic engineering projects redesign and fabricate existing biological systems as well as new biological parts, devices and systems that do not occur in nature. This Opinion discusses challenges raised by synthetic biology for public acceptance, regulation, commercialization and the emerging global issue of access to genetic resources and information. As with all new fields of research, maintaining the trust of the public and policy regulators is paramount. Hype and exaggerated claims are counterproductive to developing adaptive and ethically sound regulatory models responsive to stakeholder concerns.
UR - https://www.scopus.com/pages/publications/84858081394
U2 - 10.1016/j.tibtech.2011.10.003
DO - 10.1016/j.tibtech.2011.10.003
M3 - Review article
C2 - 22119159
AN - SCOPUS:84858081394
SN - 0167-7799
VL - 30
SP - 132
EP - 137
JO - Trends in Biotechnology
JF - Trends in Biotechnology
IS - 3
ER -